متابعة
Mark Emberton
Mark Emberton
Professor of Interventional Oncology, University College London, UK
بريد إلكتروني تم التحقق منه على ucl.ac.uk
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study‏
HU Ahmed, AES Bosaily, LC Brown, R Gabe, R Kaplan, MK Parmar, ...‏
The Lancet 389 (10071), 815-822, 2017‏
30352017
MRI-targeted or standard biopsy for prostate-cancer diagnosis‏
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...‏
New England Journal of Medicine 378 (19), 1767-1777, 2018‏
27552018
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction‏
M Oelke, A Bachmann, A Descazeaud, M Emberton, S Gravas, MC Michel, ...‏
European urology 64 (1), 118-140, 2013‏
14522013
Systematic review of complications of prostate biopsy‏
S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton, R Nam, ...‏
European urology 64 (6), 876-892, 2013‏
11752013
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting‏
L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey, JJ Futterer, ...‏
European urology 59 (4), 477-494, 2011‏
8842011
Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature‏
JJ Fütterer, A Briganti, P De Visschere, M Emberton, G Giannarini, ...‏
European urology 68 (6), 1045-1053, 2015‏
8822015
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)‏
S Madersbacher, G Alivizatos, J Nordling, CR Sanz, M Emberton, ...‏
European urology 46 (5), 547-554, 2004‏
8742004
Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review‏
CM Moore, NL Robertson, N Arsanious, T Middleton, A Villers, L Klotz, ...‏
European urology 63 (1), 125-140, 2013‏
6732013
Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review‏
M Valerio, I Donaldson, M Emberton, B Ehdaie, BA Hadaschik, LS Marks, ...‏
European urology 68 (1), 8-19, 2015‏
5242015
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group‏
CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ...‏
European urology 64 (4), 544-552, 2013‏
4632013
EAU Guidelines on benign prostatic hyperplasia (BPH)‏
JJ de la Rosette, G Alivizatos, S Madersbacher, M Perachino, D Thomas, ...‏
European urology 40 (3), 256-263, 2001‏
454*2001
How good is MRI at detecting and characterising cancer within the prostate?‏
APS Kirkham, M Emberton, C Allen‏
European urology 50 (6), 1163-1175, 2006‏
4462006
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study‏
HU Ahmed, RG Hindley, L Dickinson, A Freeman, AP Kirkham, M Sahu, ...‏
The lancet oncology 13 (6), 622-632, 2012‏
4432012
The role of focal therapy in the management of localised prostate cancer: a systematic review‏
M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ...‏
European urology 66 (4), 732-751, 2014‏
4242014
Weakly-supervised convolutional neural networks for multimodal image registration‏
Y Hu, M Modat, E Gibson, W Li, N Ghavami, E Bonmati, G Wang, ...‏
Medical image analysis 49, 1-13, 2018‏
4122018
Photodynamic therapy for prostate cancer—a review of current status and future promise‏
CM Moore, D Pendse, M Emberton‏
Nature clinical practice Urology 6 (1), 18-30, 2009‏
3892009
Benign prostatic hyperplasia: a progressive disease of aging men1‏
M Emberton, GL Andriole, J De La Rosette, B Djavan, K Hoefner, ...‏
Urology 61 (2), 267-273, 2003‏
3892003
Is it time to consider a role for MRI before prostate biopsy?‏
HU Ahmed, A Kirkham, M Arya, R Illing, A Freeman, C Allen, M Emberton‏
Nature reviews Clinical oncology 6 (4), 197-206, 2009‏
3852009
Early detection of cancer‏
D Crosby, S Bhatia, KM Brindle, LM Coussens, C Dive, M Emberton, ...‏
Science 375 (6586), eaay9040, 2022‏
3772022
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised …‏
AR Azzouzi, S Vincendeau, E Barret, A Cicco, F Kleinclauss, ...‏
The Lancet Oncology 18 (2), 181-191, 2017‏
3402017
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20